Atlas Trials

Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19

Clinical trial NCT04828564 · UNKNOWN

Trial details

NCT number
NCT04828564
Sponsor
The Scientific and Technological Research Council of Turkey
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
SARS-CoV2COVID-19
Start date
2021-04-01
Primary completion
2021-09-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.